| |
CBVI
(n=67) |
Staged BVI
(n=66) |
p-value* |
| Age (yrs), |
|
|
0.75 |
| mean(sd) |
67.7 (17.4) |
68.6 (17.5) |
|
| median(range) |
72 (10-92) |
73.5 (8-92) |
|
| Gender |
|
|
0.54 |
| Male |
32 (47.8%) |
35 (53.0%) |
|
| Female |
35 (52.2%) |
31 (47.0%) |
|
| Race |
|
|
0.09 |
| Asian |
13 (19.4%) |
18 (27.3%) |
|
| Black |
5 (7.5%) |
7 (10.6%) |
|
| Hispanic |
13 (19.4%) |
21 (31.8%) |
|
| White |
31 (46.3%) |
16 (24.2%) |
|
| Other |
5 (7.5%) |
4 (6.1%) |
|
| Glaucoma diagnosis |
|
|
1.00 |
| Angle closure |
6 (9.0%) |
7 (10.6%) |
|
| Open angle |
52 (77.6%) |
50 (75.7%) |
|
| Uveitic |
3 (4.5%) |
3 (4.6%) |
|
| Neovascular |
3 (4.5%) |
3 (4.6%) |
|
| JOAG/Congenital |
3 (45.%) |
3 (4.6%) |
|
| Lens status |
|
|
0.39 |
| Aphakic |
3 (4.5%) |
7 (10.6%) |
|
| Phakic |
20 (29.9%) |
20 (30.3%) |
|
| Pseudophakic |
44 (65.7%) |
39 (59.1%) |
|
| Previous surgeries |
|
|
|
| Cataract extraction |
48 (71.6%) |
43 (65.2%) |
0.42 |
| Trabeculectomy |
24 (35.8%) |
24 (36.4%) |
0.95 |
| Needling |
2 (3.0%) |
1 (1.5%) |
1.00 |
| Trabectome |
2 (3.0%) |
0 |
0.50 |
| Tube |
5 (7.5%) |
6 (9.1%) |
0.73 |
| Glaucoma laser |
6 (9.0%) |
9 (13.6%) |
0.39 |
| Penetrating keratoplasty |
10 (14.9%) |
10 (15.2%) |
0.97 |
| DSEK |
1 (1.5%) |
0 |
1.00 |
| Peripheral iridotomy/iridectomy |
13 (19.4%) |
25 (37.9%) |
0.02 |
| Number of previous surgeries, median (range) |
2 (0-5) |
2 (0-10) |
0.28 |
| *Independent samples t-test and Wilcoxon Rank sum tests for continuous variables, Chi-Square and Fisher’s Exact tests for categorical variables.
CBVI : Complete BVI; SBVI: Staged (two-stage) BVI |
|
